1. Home
  2. BWAY vs GFR Comparison

BWAY vs GFR Comparison

Compare BWAY & GFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • GFR
  • Stock Information
  • Founded
  • BWAY 2003
  • GFR 2018
  • Country
  • BWAY Israel
  • GFR Canada
  • Employees
  • BWAY N/A
  • GFR N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • GFR
  • Sector
  • BWAY Health Care
  • GFR
  • Exchange
  • BWAY Nasdaq
  • GFR Nasdaq
  • Market Cap
  • BWAY 280.7M
  • GFR 318.9M
  • IPO Year
  • BWAY 2019
  • GFR N/A
  • Fundamental
  • Price
  • BWAY $15.77
  • GFR $4.80
  • Analyst Decision
  • BWAY Strong Buy
  • GFR
  • Analyst Count
  • BWAY 2
  • GFR 0
  • Target Price
  • BWAY $18.00
  • GFR N/A
  • AVG Volume (30 Days)
  • BWAY 79.0K
  • GFR 50.0K
  • Earning Date
  • BWAY 11-11-2025
  • GFR 11-13-2025
  • Dividend Yield
  • BWAY N/A
  • GFR N/A
  • EPS Growth
  • BWAY 515.14
  • GFR N/A
  • EPS
  • BWAY 0.11
  • GFR 2.05
  • Revenue
  • BWAY $46,084,000.00
  • GFR $516,308,125.00
  • Revenue This Year
  • BWAY $339.49
  • GFR N/A
  • Revenue Next Year
  • BWAY $21.74
  • GFR $27.03
  • P/E Ratio
  • BWAY $54.58
  • GFR $2.31
  • Revenue Growth
  • BWAY 26.50
  • GFR N/A
  • 52 Week Low
  • BWAY $7.70
  • GFR $3.81
  • 52 Week High
  • BWAY $16.25
  • GFR $8.16
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 67.06
  • GFR 49.63
  • Support Level
  • BWAY $15.32
  • GFR $4.68
  • Resistance Level
  • BWAY $16.25
  • GFR $4.83
  • Average True Range (ATR)
  • BWAY 0.59
  • GFR 0.22
  • MACD
  • BWAY -0.07
  • GFR -0.04
  • Stochastic Oscillator
  • BWAY 70.25
  • GFR 15.05

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About GFR Greenfire Resources Ltd.

Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The Company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations.

Share on Social Networks: